Articles

For decades, pharmaceutical development treated delivery as an execution problem. Once a molecule was identified and proven, the formulation team figured out how to put it in a pill. The science was in the discovery. Everything after that was engineering.

Pharmaceutical innovation has long centered on discovery, but outcomes are increasingly shaped by how therapies are delivered. From patient adherence to bioavailability and scalability, formulation plays a critical role in real-world effectiveness. As delivery platforms evolve, they are beginning to influence not just access, but performance. Read more to explore how drug delivery is reshaping the next phase of pharma innovation.

Great patient experiences are manufactured long before the patient ever sees the product. In lyophilised ODTs, quality is the system that connects science, scale, and reliability. Explore how precision, process design, and quality systems shape real-world performance at scale.

Why the future of pharmaceutical CDMOs will be shaped not just by technology, but by the integrity of their systems.